Piper Sandler Initiates Coverage On Black Diamond Therapeutic with Overweight Rating, Announces Price Target of $11
Portfolio Pulse from richadhand@benzinga.com
Piper Sandler analyst Joseph Catanzaro has initiated coverage on Black Diamond Therapeutic (NASDAQ:BDTX) with an Overweight rating and a price target of $11.
July 14, 2023 | 11:22 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Black Diamond Therapeutic has been given an Overweight rating by Piper Sandler, with a price target of $11.
The Overweight rating from Piper Sandler indicates a positive outlook for Black Diamond Therapeutic. The price target of $11 suggests potential upside for the stock. This could lead to increased investor interest and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100